Selvita S.A. Logo

Selvita S.A.

Preclinical CRO offering integrated drug discovery and development services.

SLV | WAR

Overview

Corporate Details

ISIN(s):
PLSLVCR00029 (+1 more)
LEI:
25940057WQ9YP5MOQF28
Country:
Poland
Address:
KRAKÓW PODOLE 79, 30-394 KRAKÓW

Description

Selvita S.A. is a preclinical contract research organization (CRO) providing integrated services for the pharmaceutical and biotechnology sectors. The company offers comprehensive solutions across the drug discovery and development continuum, from target validation to preclinical candidate nomination. Core drug discovery capabilities include medicinal chemistry, pharmacology, DMPK, and protein sciences, supporting a wide range of modalities such as small molecules, antibodies, and protein degraders. For drug development, Selvita provides analytical support for small and large molecules, formulation, microbiology services, and manufacturing for clinical trials. The company operates under GMP and GLP quality standards, offering flexible engagement models that range from standalone studies to fully integrated programs.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-27 19:13
Otrzymanie zlecenia w ramach istotnej współpracy / Receipt of an Order as Part …
English 2.4 KB
2025-11-27 19:13
Otrzymanie zlecenia w ramach istotnej współpracy / Receipt of an Order as Part …
Polish 2.0 KB
2025-11-25 17:41
Zawarcie umowy o dofinansowanie w ramach programu FENG / Conclusion of the co-f…
Polish 1.0 KB
2025-11-25 17:14
Powiadomienie 2
Polish 5.2 KB
2025-11-25 17:14
Powiadomienie 1
Polish 5.3 KB
2025-11-25 17:14
Zawiadomienia od osoby pełniącej obowiązki zarządcze w Spółce / Notifications f…
Polish 971 bytes
2025-11-21 17:19
Otrzymanie istotnego zlecenia / Receipt of a significant purchase order - Conte…
Polish 1.1 KB
2025-11-21 17:01
19.1.MAR
Polish 4.4 KB
2025-11-21 17:01
19.1.MAR
Polish 4.3 KB
2025-11-21 17:01
Zawiadomienia od osoby pełniącej obowiązki zarządcze w Spółce / Notifications f…
Polish 952 bytes
2025-11-20 00:02
Jednostkowe sprawozdanie finansowe Q3 pdf
Polish 1022.9 KB
2025-11-20 00:02
Consolidated Financial Statements Q3 pdf
English 1.1 MB
2025-11-20 00:02
Skonsolidowane sprawozdanie finansowe Q3 pdf
Polish 2.2 MB
2025-11-20 00:02
Selvita Capital Group Q3 Report pdf
English 7.9 MB
2025-11-20 00:02
Sprawozdanie Zarządu z działalności (Grupa Kapitałowa) Q3 pdf
Polish 8.0 MB

Automate Your Workflow. Get a real-time feed of all Selvita S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Selvita S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Selvita S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Alpha Tau Medical Ltd. Logo
Clinical-stage oncology firm developing alpha radiation therapy for solid tumors.
United States of America
DRTS
Alteogen Inc. Logo
Biopharmaceutical firm developing biologics with proprietary drug delivery technologies.
South Korea
196170
AlzeCure Pharma Logo
Develops therapies for severe diseases, focusing on Alzheimer's and pain.
Sweden
ALZCUR
ANAPTYSBIO, INC Logo
Clinical-stage biotech developing immunology therapeutics for inflammatory diseases.
United States of America
ANAB
AngioLab, Inc. Logo
Develops angiogenesis inhibitors for pharmaceuticals and health functional foods.
South Korea
251280
Anixa Biosciences Inc Logo
A clinical-stage biotech developing therapies and vaccines to treat and prevent cancer.
United States of America
ANIX
Annovis Bio, Inc. Logo
A clinical-stage drug platform company developing therapies for neurodegenerative diseases.
United States of America
ANVS
Develops and manufactures DNA-based technologies for genetic medicine and diagnostics.
United States of America
APDN
Aprea Therapeutics, Inc. Logo
Clinical-stage biopharma developing cancer therapeutics via synthetic lethality.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases, oncology, and rare diseases.
South Korea
397030

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.